source
- FDA issues final guidance for psychedelic drug developers and announces public hearingThe FDA has completed a set of clinical guidance documents aimed at companies developing psychedelic medicines. The guidance outlines expectations for trial design, safety monitoring, and data col…
- Freenome's updated blood test shows stronger detection of precancerous lesions, boosting Abbott's market prospectsFreenome announced that its revised SimpleScreen CRC blood test met both primary and secondary goals in a pivotal validation study. The new data indicate better performance than the earlier version…